Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2010

01-01-2010

Differential Deposition of C4d and MBL in Glomeruli of Patients with ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis

Authors: Guang-qun Xing, Min Chen, Gang Liu, Xin Zheng, Jie E, Ming-hui Zhao

Published in: Journal of Clinical Immunology | Issue 1/2010

Login to get access

Abstract

Objective

Our previous study suggested involvement of alternative pathway activation of complement in ANCA-positive pauci-immune crescentic glomerulonephritis (CrGN). This study was to investigate the evidence of complement activation in renal biopsy specimens of patients with ANCA-negative pauci-immune CrGN.

Methods

Renal biopsy specimens from 12 patients with ANCA-negative pauci-immune CrGN were used to detect the staining of membrane attack complex (MAC), C3d, C4d, mannose-binding lectin (MBL), factor B by immunohistochemistry, and/or immunofluorescence. Renal tissue from eight patients with minimal change disease (MCD) and renal tissue obtained from a normal kidney and the normal parts of a nephrectomized kidney due to renal carcinoma was used as disease and normal controls, respectively.

Results

MAC and C3d could be detected in the active renal lesions of cellular crescents in each of the 12 ANCA-negative CrGN patients but not or scarcely detected in patients with MCD and in normal renal tissue. The deposition of other complement components in the 12 patients was heterogeneous. Although none of them had C1q staining, eight of the 12 were C4d positive and six out of the eight were MBL positive. The remaining four only had evidence of the alternative pathway activation by positive staining of C3d, factor B, and MAC. The staining intensity of C4d and MBL was much higher in dialysis-dependent patients than that in dialysis-independent patients.

Conclusion

Complement activation was involved in renal damage of human ANCA-negative pauci-immune CrGN but with heterogeneous activation pathways. Positive staining of C4d and MBL might be associated with poor renal outcome.
Literature
1.
2.
go back to reference Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8:314–22.PubMed Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8:314–22.PubMed
3.
go back to reference Harris AA, Falk RJ, Jennette JC. Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis. 1998;32:179–84.CrossRefPubMed Harris AA, Falk RJ, Jennette JC. Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis. 1998;32:179–84.CrossRefPubMed
4.
go back to reference Short AK, Esnault VL, Lockwood CM. Anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995;26:439–45.CrossRefPubMed Short AK, Esnault VL, Lockwood CM. Anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995;26:439–45.CrossRefPubMed
5.
go back to reference Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110:955–63.PubMed Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110:955–63.PubMed
6.
go back to reference Xiao H, Schreiber A, Heeringa P. Alternative complement pathway in the pathogenesis of disease mediated by antineutrophil cytoplasmic autoantibodies. Am J Pathol. 2007;170:52–64.CrossRefPubMed Xiao H, Schreiber A, Heeringa P. Alternative complement pathway in the pathogenesis of disease mediated by antineutrophil cytoplasmic autoantibodies. Am J Pathol. 2007;170:52–64.CrossRefPubMed
7.
go back to reference Huugen D, Esch AV, Xiao H, Peutz-kootstra CJ, Buuman WA, Tervaert JW, et al. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int. 2007;71:646–54.CrossRefPubMed Huugen D, Esch AV, Xiao H, Peutz-kootstra CJ, Buuman WA, Tervaert JW, et al. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int. 2007;71:646–54.CrossRefPubMed
8.
go back to reference Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol. 2009;20:289–98.CrossRefPubMed Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol. 2009;20:289–98.CrossRefPubMed
9.
go back to reference Chen M, Xing GQ, Yu F, Liu G, Zhao MH. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant. 2009;24:1247–52.CrossRefPubMed Chen M, Xing GQ, Yu F, Liu G, Zhao MH. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant. 2009;24:1247–52.CrossRefPubMed
10.
go back to reference Xing GQ, Chen M, Liu G, Heeringa P, Zhang JJ, Zheng X. E J, Kallenberg CG, Zhao MH. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol. 2009;29:282–91.CrossRefPubMed Xing GQ, Chen M, Liu G, Heeringa P, Zhang JJ, Zheng X. E J, Kallenberg CG, Zhao MH. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol. 2009;29:282–91.CrossRefPubMed
11.
go back to reference Hedger N, Stevens J, Drey N, Walker S, Roderick P. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant. 2000;15:1593–99.CrossRefPubMed Hedger N, Stevens J, Drey N, Walker S, Roderick P. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant. 2000;15:1593–99.CrossRefPubMed
12.
go back to reference Hung PH, Chiu YL, Lin WC, Chiang WC, Chen YM, Lin SL, et al. Poor renal outcome of antineutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc. 2006;105:804–12.CrossRefPubMed Hung PH, Chiu YL, Lin WC, Chiang WC, Chen YM, Lin SL, et al. Poor renal outcome of antineutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc. 2006;105:804–12.CrossRefPubMed
13.
go back to reference Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY. Antineutrophil cytoplasmic autoantibody negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol. 2007;18:599–605.CrossRefPubMed Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY. Antineutrophil cytoplasmic autoantibody negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol. 2007;18:599–605.CrossRefPubMed
14.
go back to reference Zhao MH, Lockwood CM. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods. 1996;197:121–30.CrossRefPubMed Zhao MH, Lockwood CM. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods. 1996;197:121–30.CrossRefPubMed
15.
go back to reference Sacks SH, Zhou W. New boundaries for complement in renal disease. J Am Soc Nephrol. 2008;19:1865–69.CrossRefPubMed Sacks SH, Zhou W. New boundaries for complement in renal disease. J Am Soc Nephrol. 2008;19:1865–69.CrossRefPubMed
16.
go back to reference Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology. 2008;149:1829–39.CrossRefPubMed Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology. 2008;149:1829–39.CrossRefPubMed
17.
go back to reference Jennette JC, Thomas DB. Pauci-immune and antineutrophil cytoplasmic autoantibody associated crescentic glomerulonephritis and vasculitis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Hepinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 644. Jennette JC, Thomas DB. Pauci-immune and antineutrophil cytoplasmic autoantibody associated crescentic glomerulonephritis and vasculitis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Hepinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 644.
18.
go back to reference Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004;65:2145–52.CrossRefPubMed Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004;65:2145–52.CrossRefPubMed
19.
go back to reference Neumann I, Regele H, Kain R, Birck R, Meis FT. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant. 2003;18:524–31.CrossRefPubMed Neumann I, Regele H, Kain R, Birck R, Meis FT. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant. 2003;18:524–31.CrossRefPubMed
20.
go back to reference Yu F, Chen M, Gao Y, Wang SX, Zou WZ, Zhao MH, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis. 2007;49:607–14.CrossRefPubMed Yu F, Chen M, Gao Y, Wang SX, Zou WZ, Zhao MH, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis. 2007;49:607–14.CrossRefPubMed
21.
go back to reference Chen M, Kallenberg CGM, Zhao MH. ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol. 2009;5:313–8.CrossRefPubMed Chen M, Kallenberg CGM, Zhao MH. ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol. 2009;5:313–8.CrossRefPubMed
22.
go back to reference Wang F, Chen M, Zhao MH. Circulating neutrophil degranulation is involved in ANCA-negative pauci-immune crescentic glomerulonephritis. J Nephrol. 2009;22:491–6.PubMed Wang F, Chen M, Zhao MH. Circulating neutrophil degranulation is involved in ANCA-negative pauci-immune crescentic glomerulonephritis. J Nephrol. 2009;22:491–6.PubMed
23.
go back to reference Cong M, Chen M, Zhang JJ, Hu Z, Zhao MH. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis. Nephrology (Carlton). 2008;13:228–34.CrossRef Cong M, Chen M, Zhang JJ, Hu Z, Zhao MH. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis. Nephrology (Carlton). 2008;13:228–34.CrossRef
24.
go back to reference Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev. 2001;180:35–48.CrossRefPubMed Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev. 2001;180:35–48.CrossRefPubMed
25.
go back to reference Schulze M, Pruchno CJ, Burns M, Baker PJ, Johnson RJ, Couser WG. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol. 1993;142:179–87.PubMed Schulze M, Pruchno CJ, Burns M, Baker PJ, Johnson RJ, Couser WG. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol. 1993;142:179–87.PubMed
26.
go back to reference Chakravarti DN, Campbell RD, Porter RR. The chemical structure of the C4d fragment of the human complement component C4. Mol Immunol. 1987;24:1187–97.CrossRefPubMed Chakravarti DN, Campbell RD, Porter RR. The chemical structure of the C4d fragment of the human complement component C4. Mol Immunol. 1987;24:1187–97.CrossRefPubMed
27.
go back to reference Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis. Am J Kidney Dis. 2001;38:1082–88.CrossRefPubMed Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis. Am J Kidney Dis. 2001;38:1082–88.CrossRefPubMed
28.
29.
go back to reference Dahl MR, Thiel M, Matsushita T, Fujita T, Willis A, Christensen T, et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity. 2001;15:127–35.CrossRefPubMed Dahl MR, Thiel M, Matsushita T, Fujita T, Willis A, Christensen T, et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity. 2001;15:127–35.CrossRefPubMed
30.
go back to reference Matsushita M, Endo Y, Fujita T. Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol. 2000;164:2281–4.PubMed Matsushita M, Endo Y, Fujita T. Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol. 2000;164:2281–4.PubMed
31.
go back to reference Roos A, Rastaldi MP, Calvaresi N. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol. 2006;17:1724–34.CrossRefPubMed Roos A, Rastaldi MP, Calvaresi N. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol. 2006;17:1724–34.CrossRefPubMed
32.
go back to reference Nauta AJ, Raaschou-Jensen N, Roos A, Daha MR, Madsen HO, Borrias-Essers MC, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol. 2003;33:2853–63.CrossRefPubMed Nauta AJ, Raaschou-Jensen N, Roos A, Daha MR, Madsen HO, Borrias-Essers MC, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol. 2003;33:2853–63.CrossRefPubMed
33.
go back to reference Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol. 2007;18:1046–56.CrossRefPubMed Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol. 2007;18:1046–56.CrossRefPubMed
34.
go back to reference Cohen D, Koopmans M, Kremer Hovinga IC, Berger SP, van Roos Groningen M, Steup-Beekman GM, et al. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum. 2008;58:2460–9.CrossRefPubMed Cohen D, Koopmans M, Kremer Hovinga IC, Berger SP, van Roos Groningen M, Steup-Beekman GM, et al. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum. 2008;58:2460–9.CrossRefPubMed
35.
go back to reference Ohsawa I, Ohi H, Endo M, Fujita T, Matsushita M, Fujita T. Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritis. Kidney Int. 1999;56:1158–60.CrossRefPubMed Ohsawa I, Ohi H, Endo M, Fujita T, Matsushita M, Fujita T. Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritis. Kidney Int. 1999;56:1158–60.CrossRefPubMed
36.
go back to reference Hisano S, Matsushita M, Fujita T, Iwasaki H. Activation of the lectin complement pathway in Henoch–Schonlein purpura nephritis. Am J Kidney Dis. 2005;45:295–302.CrossRefPubMed Hisano S, Matsushita M, Fujita T, Iwasaki H. Activation of the lectin complement pathway in Henoch–Schonlein purpura nephritis. Am J Kidney Dis. 2005;45:295–302.CrossRefPubMed
37.
go back to reference European Vasculitis Study Group (EUVAS), de Lind Van Wijngaarden RAF, Hauer HA, Wolterbeek R, Jayne DRW, Rasmussen GN, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol. 2006;17:2264–74.CrossRefPubMed European Vasculitis Study Group (EUVAS), de Lind Van Wijngaarden RAF, Hauer HA, Wolterbeek R, Jayne DRW, Rasmussen GN, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol. 2006;17:2264–74.CrossRefPubMed
38.
go back to reference Seelen MA, Roos A, Daha MR. Role of complement in innate and autoimmunity. J Nephrol. 2005;18:642–53.PubMed Seelen MA, Roos A, Daha MR. Role of complement in innate and autoimmunity. J Nephrol. 2005;18:642–53.PubMed
Metadata
Title
Differential Deposition of C4d and MBL in Glomeruli of Patients with ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis
Authors
Guang-qun Xing
Min Chen
Gang Liu
Xin Zheng
Jie E
Ming-hui Zhao
Publication date
01-01-2010
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2010
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9344-2

Other articles of this Issue 1/2010

Journal of Clinical Immunology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.